These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1703370)

  • 21. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
    Edwards MJ; Dimmock NJ
    J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins.
    Besselaar TG; Blackburn NK
    Arch Virol; 1992; 125(1-4):239-50. PubMed ID: 1642552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for the G1 protein of California encephalitis virus in infection in vitro and in vivo.
    Hacker JK; Volkman LE; Hardy JL
    Virology; 1995 Feb; 206(2):945-53. PubMed ID: 7531919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses.
    Gonzalez-Scarano F; Shope RE; Calisher CH; Nathanson N
    Prog Clin Biol Res; 1983; 123():145-56. PubMed ID: 6191341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
    Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
    J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. La Crosse encephalitis: occurrence of disease and control in a suburban area.
    Thompson WH; Gundersen CB
    Prog Clin Biol Res; 1983; 123():225-36. PubMed ID: 6867036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus.
    Sundin DR; Beaty BJ; Nathanson N; Gonzalez-Scarano F
    Science; 1987 Jan; 235(4788):591-3. PubMed ID: 3810159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sindbis virus conformational changes induced by a neutralizing anti-E1 monoclonal antibody.
    Hernandez R; Paredes A; Brown DT
    J Virol; 2008 Jun; 82(12):5750-60. PubMed ID: 18417595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of neutralizing monoclonal antibodies on Hantaan virus infection of the macrophage P388D1 cell line.
    Yao JS; Arikawa J; Kariwa H; Yoshimatsu K; Takashima I; Hashimoto N
    Jpn J Vet Res; 1992 Sep; 40(2-3):87-97. PubMed ID: 1284283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro mechanisms of monoclonal antibody neutralization of alphaviruses.
    Roehrig JT; Hunt AR; Kinney RM; Mathews JH
    Virology; 1988 Jul; 165(1):66-73. PubMed ID: 2455383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
    Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
    J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of potent neutralizing monoclonal antibodies from an SIV-Infected rhesus macaque by phage display.
    Kuwata T; Katsumata Y; Takaki K; Miura T; Igarashi T
    AIDS Res Hum Retroviruses; 2011 May; 27(5):487-500. PubMed ID: 20854170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies.
    Li C; Li W; Lucio de Esesarte E; Guo H; van den Elzen P; Aarts E; van den Born E; Rottier PJM; Bosch BJ
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of neutralization of influenza virus infectivity by antibodies.
    Knossow M; Gaudier M; Douglas A; Barrère B; Bizebard T; Barbey C; Gigant B; Skehel JJ
    Virology; 2002 Oct; 302(2):294-8. PubMed ID: 12441073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism.
    Ma M; Kersten DB; Kamrud KI; Wool-Lewis RJ; Schmaljohn C; González-Scarano F
    Virus Res; 1999 Oct; 64(1):23-32. PubMed ID: 10500280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The development of neutralizing human antibodies against rabies virus].
    Chen Z; Sun LN; Li C; Lv XJ; Tang Q; Liang MF; Li DX
    Bing Du Xue Bao; 2010 Jul; 26(4):271-5. PubMed ID: 20836379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and localization of conserved antigenic epitopes on the G2 proteins of California serogroup Bunyaviruses.
    Cheng LL; Schultz KT; Yuill TM; Israel BA
    Viral Immunol; 2000; 13(2):201-13. PubMed ID: 10893000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
    Barbas CF; Björling E; Chiodi F; Dunlop N; Cababa D; Jones TM; Zebedee SL; Persson MA; Nara PL; Norrby E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9339-43. PubMed ID: 1384050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.